Brightside Psychiatry
Precision medication management for anxiety and depression with 70% response rate at first medication
Platform · Cloud SaaSCompany source
Company profile
About Brightside Health
Brightside Health is a virtual mental health care provider specializing in evidence-based treatment for anxiety and depression across the full spectrum of severity. The company offers personalized psychiatry services utilizing a precision-prescribing engine that analyzes 100+ data points, clinically-proven therapy based on cognitive and behavioral approaches, and specialized programs including a Suicide Prevention Program based on the Collaborative Assessment and Management of Suicidality (CAMS) framework. Brightside also provides teen care for ages 13 and up, and Intensive Outpatient Programs for mental health. The company's care model combines 1:1 video sessions with licensed providers, anytime messaging, interactive lessons, and proactive progress tracking through weekly check-ins. Brightside serves both direct-to-consumer patients and partners with health plans, health systems, and medical groups to reduce emergency department utilization and improve quality measures. The platform accepts most major insurance including Medicare and Medicaid, with 92% of patients able to start treatment within five days. Brightside's measurement-based approach has demonstrated peer-reviewed outcomes including 75% remission rates within 12 weeks and 77% reduction in suicidal thoughts, with response and remission rates 30-50% higher than leading U.S. health systems.
Company description Brightside Health official website
Primary marketMental Health & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Brightside Health?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Bipolar disorder
- Generalized anxiety disorder
- Insomnia
- Major depressive disorder
- Obsessive-compulsive disorder (OCD)
- Panic disorder
- Phobia
- Post-traumatic stress disorder (PTSD)
- Postpartum depression
- Premenstrual dysphoric disorder (PMDD)
- Seasonal affective disorder
- Social anxiety disorder
- Suicidal ideation
Who it serves
- Adults
- Direct-to-consumer patients
- Health Plans
- Health Systems
- Medical Groups
- Teens ages 13+
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: ADT notifications, EHR integration for discharge planning.
Geographic context
MarketsNationwide network of providers · United States
Company sourceOfficial website
Company milestones
Platform expansion
Launch of Teen Care program for ages 13+, expansion to 150 million covered lives through health plan partnerships, introduction of Intensive Outpatient Programs
Partnerships
Recorded partners
- 150 million lives covered through health plan partnerships
- Medical groups
- Multiple health systems
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Brightside Therapy
Clinically-proven virtual therapy combining cognitive and behavioral therapy with independent skill practice
Platform · Cloud SaaSCompany source
Health Plan Risk Reduction Program
Comprehensive solution to reduce health plan risk, improve quality measures, and lower total cost of care
Platform · Cloud SaaSCompany source
Intensive Outpatient Program (IOP)
Technology-enabled intensive outpatient mental health care for measurable clinical and financial impact
Platform · Cloud SaaSCompany source
Suicide Prevention Program
First-of-its-kind virtual program for individuals with elevated suicide risk based on CAMS framework
Platform · Cloud SaaSCompany source
Teen Care
Expert mental health support for teens ages 13+ with specialized therapists and psychiatry when needed
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Evaluating the Impact of a National Telehealth Outpatient Mental Health Program in Rural Communities.Healthcare (Basel, Switzerland) · Jun 2, 2026
Patient Engagement in Providing Telehealth SUD IOP Treatment: A Retrospective Cohort Study.Healthcare (Basel, Switzerland) · Dec 18, 2024
Large Language Models Versus Expert Clinicians in Crisis Prediction Among Telemental Health Patients: Comparative Study.JMIR mental health · Aug 2, 2024
The utility of completing adjuvant video lessons based on the unified protocol during psychotherapy: A retrospective study using a telehealth platform in routine clinical care.Psychotherapy research : journal of the Society for Psychotherapy Research · Feb 1, 2024
Novel Telehealth Adaptations for Evidence-Based Outpatient Suicide Treatment: Feasibility and Effectiveness of the Crisis Care Program.Healthcare (Basel, Switzerland) · Dec 13, 2023
Symptom clustering of major depression in a national telehealth sample.Journal of affective disorders · Oct 1, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
77% of people no longer had suicidal thoughts
after 12 weeks of treatment (JMIR 2022)
75% remission rate
within 12 weeks (BMC 2022)
30-50% higher response and remission rates
compared to leading U.S. health system (Cureus 2022)
70% response rate
at first medication
92% appointment access
within 5 days
Brightside Clinical Study
Treatment of patients with elevated suicide risk
57-77% of people no longer had any suicidal thoughts after just 12 weeks of treatment
Leading U.S. Health System
Comparison study of depression and anxiety treatment outcomes
30-50% higher response and remission rates than the health system
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Brightside Health
Recent articles published on Brightside Health's official website.
PTSD Statistics: Recent Data and Insights
Read on Brightside HealthPTSD Symptoms in Men
Read on Brightside HealthCPTSD vs BPD: What’s the Difference?
Read on Brightside HealthIs OCD Neurodivergent? Understanding the Debate
Read on Brightside HealthWhat is Relationship PTSD? Signs, Symptoms & Treatment
Read on Brightside Health07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Mental Health & Digital Therapeutics
Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.